Prof. Qingkai Meng 孟庆凯
Chief Physician, Professor
Department of Colorectal Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of colorectal tumors, including early diagnosis, laparoscopic minimally invasive surgery, function-preserving rectal cancer surgery, combined organ resection, and management of recurrent or metastatic disease.
Dr. Meng is Director of the Fourth Colorectal Ward, Chief Physician, Professor, and Master’s Supervisor at Liaoning Cancer Hospital & Institute. Dr. Meng holds a medical doctorate, leads three provincial science and technology fund projects, and has published dozens of papers in SCI and national core journals.
Professional roles
- Member, Colorectal Cancer Professional Committee, China Anti-Cancer Association
- Member, Accelerated Recovery Surgery after Colorectal Tumor Professional Committee, Chinese Medical Doctor Association
- Standing Committee Member, Gastrointestinal Surgery Branch, China Geriatric Medical Research Association
- Standing Committee Member, Liver Cancer Professional Committee, Liaoning Anti-Cancer Association
Name order: in Chinese the family name comes first (Meng Qingkai). Papers usually list the name as Qingkai Meng or Meng Q.
Selected publications
16 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Gastrointest Endosc, 2024 (senior author): Characteristics of factors for metachronous risk after endoscopic resection of serrated polyps. PubMed 39643384
- Gastrointest Endosc, 2024 (senior author): Watch and wait or endoscopic hemostasis: delayed bleeding after colorectal endoscopic submucosal dissection. PubMed 39182965
- Gastrointest Endosc, 2024 (senior author): The role of artificial intelligence-assisted endoscopy surveillance in clinical practice: controversies and future perspectives. PubMed 39025600
- Dis Markers, 2022 (senior author): Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis. PubMed 35711569
- Transl Cancer Res, 2021 (senior author): The predictive and prognostic value of sex in localized colorectal cancer: a SEER-based analysis. PubMed 35116531
- Eur J Cancer, 2019 (senior author): Comment on 'Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery'. PubMed 30909070
- Exp Ther Med, 2019 (senior author): MicroRNA-761 is downregulated in colorectal cancer and regulates tumor progression by targeting Rab3D. PubMed 30783458
- Int J Colorectal Dis, 2019 (senior author): Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis. PubMed 30368569
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion